Prilenia Therapeutics

3 open jobs

Prilenia Therapeutics is a clinical-stage biotechnology company focused on developing novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders. The company is conducting global Phase 3 clinical trials for its lead product candidate, pridopidine, in Huntington's Disease and ALS, with Orphan Drug Designation and FDA Fast Track designation.